Understanding how shared decision‐making approaches and patient aids influence patients with advanced cancer when deciding on palliative treatments and care: A …
M Edwards, D Holland‐Hart, M Mann… - Health …, 2023 - Wiley Online Library
Background Patients with advanced incurable cancer face difficult decisions about palliative
treatment options towards their end of life. However, they are often not provided with the …
treatment options towards their end of life. However, they are often not provided with the …
A systematic review of the effectiveness of decision making interventions on increasing perceptions of shared decision making occurring in advanced cancer …
G Punnett, C Eastwood, L Green, J Yorke - Patient Education and …, 2024 - Elsevier
Objective To determine how decision making interventions for use in advanced cancer
treatment consultations function and whether they increase perceptions of shared decision …
treatment consultations function and whether they increase perceptions of shared decision …
[HTML][HTML] “The challenge is the complexity”–A qualitative study about decision-making in advanced lung cancer treatment
S Orstad, Ø Fløtten, T Madebo, P Gulbrandsen… - Lung Cancer, 2023 - Elsevier
Introduction The value of shared decision-making and decision aids (DA) has been well
documented yet remain difficult to integrate into clinical practice. We wanted to investigate …
documented yet remain difficult to integrate into clinical practice. We wanted to investigate …
[HTML][HTML] Neoadjuvant immunotherapy followed by surgery with curative intent in 35 patients with advanced NSCLC: the retrospective experiences of a multidisciplinary …
D Ma, Y Xu, Y Qin, S Li, J Li, Y Jiang… - Annals of …, 2022 - ncbi.nlm.nih.gov
Background In recent years, neoadjuvant immunotherapy combined with chemotherapy has
been used to treat locally advanced non-small cell lung cancer (NSCLC); however, no data …
been used to treat locally advanced non-small cell lung cancer (NSCLC); however, no data …
Experiences of cancer immunotherapy with immune checkpoint inhibitors (ExCIm)—insights of people affected by cancer and healthcare professionals: a qualitative …
S Jennings, S Anstey, J Bower, A Brewster… - BMJ open, 2021 - bmjopen.bmj.com
Introduction There is a global interest in cancer immunotherapy. Clinical trials have found
that one group, immune checkpoint inhibitors (ICIs), has demonstrated clinical benefits …
that one group, immune checkpoint inhibitors (ICIs), has demonstrated clinical benefits …
[HTML][HTML] Hope and meaning-making in phase 1 oncology trials: a systematic review and thematic synthesis of qualitative evidence on patient-participant experiences
K Escritt, M Mann, A Nelson, E Harrop - Trials, 2022 - Springer
Background Phase 1 drug trials are popular treatment options for patients with advanced
disease, despite the greater levels of uncertainty associated with them. However, their …
disease, despite the greater levels of uncertainty associated with them. However, their …
[HTML][HTML] Negotiating decisions on aggressive cancer care at end-of-life between patients, family members, and physicians–A qualitative interview study
MW Haun, A Wildenauer, M Hartmann, C Bleyel… - Frontiers in …, 2022 - frontiersin.org
Background: Patients with advanced cancer do receive increasingly aggressive end-of-life
care (AOC), despite it does often not prolong survival time but entails decreased quality of …
care (AOC), despite it does often not prolong survival time but entails decreased quality of …
How do patients make decisions in the context of a multidisciplinary team: an ethnographic study of four head and neck cancer centres in the north of England
Objectives To describe how patients are engaged with cancer decisions in the context of
multidisciplinary team (MDT) and how MDT recommendations are operationalised in the …
multidisciplinary team (MDT) and how MDT recommendations are operationalised in the …